scholarly article | Q13442814 |
P356 | DOI | 10.1042/BJ20101104 |
P698 | PubMed publication ID | 20958264 |
P50 | author | Sahng Wook Park | Q60981161 |
Mijin Yun | Q61151102 | ||
P2093 | author name string | Hyo-Jeong Kim | |
Jae-Woo Kim | |||
Jong-Seok Moon | |||
Kyung-Sup Kim | |||
Won-Ji Jin | |||
Jin-Hye Kwak | |||
P2860 | cites work | High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase | Q24561487 |
Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase | Q28115329 | ||
Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase gene (PFKFB3) | Q28138539 | ||
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme | Q28290284 | ||
Androgen receptor in prostate cancer | Q29616454 | ||
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. | Q31879172 | ||
Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B. | Q33179024 | ||
PTEN, a unique tumor suppressor gene | Q33974014 | ||
Multiple forms of hexokinase in the rat: tissue distribution, age dependency, and properties | Q34053490 | ||
Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies | Q34067149 | ||
Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation | Q34357440 | ||
Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors. | Q34422480 | ||
Androgen receptors in prostate cancer | Q34866937 | ||
Androgens, lipogenesis and prostate cancer. | Q36017037 | ||
Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins | Q36714297 | ||
KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells. | Q38287719 | ||
Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene | Q38355181 | ||
Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells. | Q38499941 | ||
Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer | Q40382360 | ||
Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130. | Q41661472 | ||
Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A. | Q43298914 | ||
FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. | Q43707212 | ||
Glucose metabolism in cancer: importance of transcription factor-DNA interactions within a short segment of the proximal region og the type II hexokinase promoter | Q44534309 | ||
Phosphorylation and Activation of Heart 6-Phosphofructo-2-kinase by Protein Kinase B and Other Protein Kinases of the Insulin Signaling Cascades | Q57800756 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P1104 | number of pages | 9 | |
P304 | page(s) | 225-233 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Biochemical Journal | Q864221 |
P1476 | title | Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells | |
P478 | volume | 433 |
Q90556178 | 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer |
Q39124486 | A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer. |
Q45169319 | Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis |
Q39795284 | Akt-dependent activation of the heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids. |
Q37610799 | Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies |
Q53476667 | Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes. |
Q39067480 | Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch. |
Q38166477 | Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism |
Q37564733 | Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer |
Q53699332 | Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches. |
Q39512219 | Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines? |
Q49307514 | Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells |
Q64271866 | Effect of PTEN loss on metabolic reprogramming in prostate cancer cells |
Q39200208 | Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration |
Q43139072 | Fatty acid synthesis and NLRP3-inflammasome |
Q58764753 | Fructose 2,6-Bisphosphate in Cancer Cell Metabolism |
Q34274098 | Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. |
Q50066658 | GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. |
Q37014362 | Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet |
Q47977198 | Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67. |
Q36681426 | Hexokinase is a key regulator of energy metabolism and ROS activity in insect lifespan extension |
Q28393898 | Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells |
Q34035683 | Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations |
Q42118494 | Incidental detection of prostate-specific antigen-negative metastatic prostate cancer initially presented with solitary pulmonary nodule on fluorodeoxyglucose positron emission tomography/computed tomography |
Q38737293 | Kallikrein-related peptidases (KLKs) and the hallmarks of cancer |
Q38002682 | Lipids and prostate cancer |
Q92073772 | LncRNAs: The Regulator of Glucose and Lipid Metabolism in Tumor Cells |
Q27014979 | Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells |
Q90642651 | Metabolic Plasticity in Chemotherapy Resistance |
Q38936250 | Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer. |
Q39095849 | Metabolic alterations during the growth of tumour spheroids |
Q54350939 | Metabolic differences in estrogen receptor-negative breast cancer based on androgen receptor status. |
Q34749943 | N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor |
Q34336533 | PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli |
Q41126547 | PFKL/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer |
Q60921025 | PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review) |
Q51357703 | Phosphofructokinase-P Modulates P44/42 MAPK Levels in HeLa Cells. |
Q92410918 | Prostate Cancer Energetics and Biosynthesis |
Q37537958 | Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches |
Q38616121 | Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression |
Q52663598 | SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway. |
Q92522698 | Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis |
Q38132274 | Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy |
Q38323902 | Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer |
Q47379977 | The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas? |
Q38096735 | The fat side of prostate cancer |
Q89948640 | Tumour metabolism and its unique properties in prostate adenocarcinoma |
Q55058557 | UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation. |
Q33647013 | Vitamin D, intermediary metabolism and prostate cancer tumor progression |
Search more.